Molecular Dynamics Protocols for the Study of Cyclodextrin Drug Delivery Systems

Area of Science:

• Pharmacology and Computational Chemistry
• Drug Discovery and Development

Background:

• Hypertension is a growing global health concern requiring effective treatments.
• Marketed drugs like sartans can be improved pharmacologically.
• Irbesartan (IRB) is a potent sartan but suffers from high lipophilicity, limiting its therapeutic index.

Purpose of the Study:

• To present a computational scheme for enhancing the pharmacological profile of irbesartan (IRB).
• To investigate the association between IRB and cyclodextrins as a strategy to improve hydrophilicity.
• To provide a detailed computational protocol applicable to other drugs with poor hydrophilic character.

Main Methods:

• Utilized a combination of computational techniques: molecular docking, quantum mechanics, molecular dynamics, and free energy calculations.
• Studied the interactions and energetic contributions governing the IRB:cyclodextrin complex formation.
• Developed a comprehensive computational protocol for drug property enhancement.

Main Results:

• The study successfully modeled the IRB:cyclodextrin association, providing insights into interaction mechanisms.
• Quantified the energetic contributions governing the complex formation.
• Established a validated computational protocol for improving drug physicochemical properties.

Conclusions:

• Computational methods offer a powerful approach to enhance the pharmacological properties of drugs like irbesartan.
• Cyclodextrins show promise as carriers to improve the hydrophilicity and therapeutic index of lipophilic drugs.
• The developed protocol can guide the optimization of sartans and other drug molecules.